Any current/future new fundraising through debt or equity?

As of now, Manorama Industries has no immediate plans for external financing through debt or equity. The company primarily relies on strong internal cash accruals to fund its planned capex projects over the next 2 to 3 years. Options for external financing will be considered selectively if necessary, but currently there are no active plans for raising funds externally.

Any current/future capex/capital investment/strategic investment?

Manorama Industries has announced a capex plan of around INR 460 crores, to be deployed over the next 2-3 years. The capex includes: - Addition of 75,000 MTPA solvent fractionation capacity for new products like ESOS and HPMF. - A new 75,000 MTPA capacity for cocoa butter alternative (CBA) including specialty fats. - Expansion of refinery capacity by 90,000 MTPA, linked to the new fractionation capacity. - A backward integration project in Burkina Faso (land acquired) alongside expansion in West Africa. The capex is primarily funded from strong internal accruals, with no immediate plan

Future growth expectations in sales/revenue/volumes?

Company expects 40%-45% growth in volume over next 1-2 years due to 30% increase in capacity and 15% available in existing capacity. Revenue growth is anticipated commensurate or above 30% with new capacity expansion. Existing capacities support growth for next 1-2 years; planned capex will drive growth for 4-5 years. New projects include 75,000 MTPA fractionation capacity and 90,000 MTPA refinery capacity, targeting a 5x or higher asset turnover. Volume growth contributed majorly to 73%-81% Y-o-Y revenue increase recently, with ~65%-90% volume growth depending on periods. Working capital cycl

Future growth expectations in earnings/operating earnings/profits/EPS?

Manorama Industries expects approximately 40%-45% growth in capacity utilization over the next 1-2 years, translating into strong revenue growth, with a target of more than 30% increase. The company anticipates EBITDA margins to remain sustainable in the range of 25%-27%, supported by improved product mix, higher capacity utilization, and operational efficiencies. The new capex of INR 460 crores, primarily funded through internal accruals, aims to enable 4-5 years of growth, with asset turns expected to exceed 5x, potentially adding around INR 2,000 crores to topline over the next 3 years. Wor

IN US

Sale is live|00:00:00left today

Manorama Industries LtdQ4 FY27Food Products

Manorama Industries Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,574P/E: 33.4Market Cap: ₹7.8K CrSector: Food Products

Management growth scorecard

Revenue

Category 1

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 1

→Company expects 40%-45% growth in volume over next 1-2 years due to 30% increase in capacity and 15% available in existing capacity.
→Revenue growth is anticipated commensurate or above 30% with new capacity expansion.
→Existing capacities support growth for next 1-2 years; planned capex will drive growth for 4-5 years.
→New projects include 75,000 MTPA fractionation capacity and 90,000 MTPA refinery capacity, targeting a 5x or higher asset turnover.
→Volume growth contributed majorly to 73%-81% Y-o-Y revenue increase recently, with ~65%-90% volume growth depending on periods.
→Working capital cycle expected to improve with new product lines requiring lower inventory periods.
→Overall, the company is confident of strong sustainable growth for coming years backed by capacity expansion and product mix enhancement.

Margin guidance

Category 3

→Manorama Industries expects approximately 40%-45% growth in capacity utilization over the next 1-2 years, translating into strong revenue growth, with a target of more than 30% increase.
→The company anticipates EBITDA margins to remain sustainable in the range of 25%-27%, supported by improved product mix, higher capacity utilization, and operational efficiencies.
→The new capex of INR 460 crores, primarily funded through internal accruals, aims to enable 4-5 years of growth, with asset turns expected to exceed 5x, potentially adding around INR 2,000 crores to topline over the next 3 years.
→Working capital cycle is expected to improve, especially for new forward integration projects, reducing from current ~120 days to around 1-3 months for new products.
→Forward integration projects and product innovation (e.g., cocoa butter alternatives) are expected to be margin-neutral or accretive, supporting consistent earnings growth.

3 more insights locked — sign up free to unlock

Fundraise plans

→As of now, Manorama Industries has no immediate plans for external financing through debt or equity.
→The company primarily relies on strong internal cash accruals to fund its planned capex projects over the next 2 to 3 years.
→Options for external financing will be considered selectively if necessary, but currently there are no active plans for raising funds externally.

Order book

The provided transcript does not explicitly mention current or expected orderbook or pending orders details for Manorama Industries Limited. However, from the discussion, the following points can be inferred: - The company is experiencing strong growth and demand with capacity expansions planned and ongoing. - There is approximately 40-45% growth opportunity available in the next 1-2 years on existing and new capacity. - The company is confident about good revenue growth in the coming years, expecting over 30% increase aligned with new capacities. - Expansion projects (including 75,000 MTPA capacities for new products like CBE and solvent fractionation) are progressing and expected to ramp up over next 1-3 years. - Customer relationships are strong and product is customized and application-specific, suggesting a steady order inflow. No specific quantitative orderbook or pending order values were disclosed in the call excerpt.

Capex plans

Yes

→Manorama Industries has announced a capex plan of around INR 460 crores, to be deployed over the next 2-3 years.
→The capex includes:
→ - Addition of 75,000 MTPA solvent fractionation capacity for new products like ESOS and HPMF.
→ - A new 75,000 MTPA capacity for cocoa butter alternative (CBA) including specialty fats.
→ - Expansion of refinery capacity by 90,000 MTPA, linked to the new fractionation capacity.
→ - A backward integration project in Burkina Faso (land acquired) alongside expansion in West Africa.
→The capex is primarily funded from strong internal accruals, with no immediate plans for external financing.
→Expected asset turnover is over 5x, with potential top-line addition of around INR 2,000 crores over 3 years.
→New capacities are expected to be operational in phases from FY'27 to FY'29.
→The working capital cycle for new products is expected to be shorter (1-3 months) compared to existing business.

How does Manorama Industries Ltd rank vs peers in Food Products?

Pro feature

1Manorama Industries Ltd

Rev 1Mar 3

See full Food Products sector rankings

Want more stocks like Manorama Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio